Skip to main content

Gynecological Pathology 2022: Essential Knowledge for Diagnostic Practice

Original release date:
January 27, 2023
Access to this course expires on:  December 9, 2025 at 11:59 PM Pacific Time
CME 18

Course Description
As a major clinical subspecialty, diagnostic gynecological pathology involves a large number of disease entities and often complex histological variants. Recent developments, particularly molecular genetic discoveries, have introduced new and reclassified entities as well as refined diagnostic criteria for many existing disease processes, calling for knowledge update for practicing pathologists. This unique course offers an engaged learning experience with world-class faculty delegated from the International Society of Gynecological Pathologists (ISGyP). While providing comprehensive coverage, the course emphasizes knowledge gains in morphologic recognition and using ancillary immunohistochemistry and molecular genetic studies in the most challenging areas, particularly new disease classifications/diagnostic criteria.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize updated diagnostic criteria and disease classifications in gynecological pathology
  • Recognize unusual but important gynecological disease entities
  • Apply immunohistochemical and molecular genetic studies for diagnosis and differential diagnoses
  • Understand the clinical implications when applying new diagnostic knowledge in gynecological pathology

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of United States and Canadian Academy of Pathology (USCAP) and International Society for Gynecological Pathologists (ISGYP). The USCAP is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 18  AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Pei Hui, MD, PhD, Ricardo R. Lastra, MD, Xavier Matias-Guiu, MD, Marisa Rose Nucci, MD, Naveena Singh, MD, FRCPath, and Russell S. Vang, MD

The following IM Coordinator reported no relevant financial relationships: Oluwole Fadare, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.